Andrea Dalton

Senior Litigation Attorney

Denver divorce attorney Andrea DaltonDenver divorce attorney Andrea Dalton understands just how delicate family law matters can be.

“Working with clients who are going through a life-changing event as personal as a family law matter is much like a person going through a catastrophic injury,” Ms. Dalton said. “It is just a different kind of ‘catastrophic’ event, but takes the same level of attention, tenacity, and care.”

Ms. Dalton is patient with each of her clients and tenacious while working to make sure their rights are protected.

There are typically many ups and downs involved in any divorce case, so Ms. Dalton encourages her clients to keep their focus on the finish line.

“If you get mad, you lose,” she said. “I urge patience and trust in your counsel and your team. I will ensure the very best counsel and team, and will do the worrying for you, but we are a team and as a team we need to craft the best arguments, the best strategy, and gather the best discovery.

“Let’s put our best foot forward, be professional, and work together towards getting you and your children the best result.”

Licenses & Admissions

Ms. Dalton is licensed to practice in Colorado.


Ms. Dalton received her Bachelor of Arts and Bachelor of Science from the University of Wyoming. She earned her Juris Doctor from the University of Denver.

Professional Experience

Prior to joining Cordell & Cordell, Ms. Dalton practiced adverse drug reactions, Steven Johnson Syndrome Litigations, products liability, trial practice, pharmaceutical litigation, and nationwide medical malpractice litigation.


  • United States District Court for the District of Colorado
  • Colorado State Court
  • Ohio State Court
  • United States District Court for the Western District of Michigan
  • Supreme Court of the United States
  • William E. Doyle Inn of Court – Barrister Member (Denver)
  • Lawyers Without Borders
  • Million Dollar Trial Lawyers

Speeches, Seminars, & Publications

  • National Institute of Health presentation 2014 on Behalf of Stevens Johnson Syndrome Foundation, Bethesda Maryland: Adverse Event Reporting to the FDA and Stevens Johnson Syndrome
  • “Research Directives in Genetically Mediated Stevens Johnson Syndrome/Toxic Epidermal Necrolysis,” National Institute of Health, March 2014; Journal of Clinical Pharmacology, September 2017
  • “Dangerous Doses,” The Chicago Tribute, February 12, 2016